Department of Health Management, School of Health Management, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21205, USA.
Int J Equity Health. 2022 Apr 29;21(1):57. doi: 10.1186/s12939-022-01666-9.
This study aimed to compare the prevention and control strategies adopted by the United States and India in the COVID-19 outbreak and analyze the effectiveness of their strategies, in order to provide empirical experience for the prevention and control of the epidemic.
This study extracted official data on COVID-19 from various official websites, summarized the policies in place in the United States and India, and evaluated the effectiveness of their policies.
The United States has adopted a series of mitigation strategies to control the two waves of epidemic, including strengthening virus detection, calling on the people to wear masks and so on. As of May 30, 2021, although the daily new cases there decreased to some extent, the effect was not ideal. The US's daily new cases ranked fourth and the cumulative number of confirmed cases ranked first in the world. India has adopted containment strategies in the initial stage of the outbreak, making the epidemic relatively stable. In the later stage, India has turned to adopt mitigation strategies. In addition, many factors including the lack of medical resources and premature relaxation measures led to the rapid deterioration of the epidemic situation. As of May 30, 2021, although the daily new cases in India has a downward trend, it ranked first in the world, and the cumulative number of confirmed cases ranked second.
There are differences between the epidemic prevention strategies adopted by the United States and India, especially India's containment strategies which helped it better control the epidemic in the early stage. However, the epidemic in the two countries is still severe. With the advent of virus mutants and the absence of immune barriers, it is meaningful that the two countries continue to take non-pharmacotherapy intervention measures and accelerate vaccination, according to specific national conditions adopt containment strategies that can control the epidemic more quickly when necessary, and pay attention to the risk of epidemic rebound caused by premature relaxation of epidemic prevention policies.
本研究旨在比较美国和印度在 COVID-19 爆发期间采取的预防和控制策略,并分析其策略的有效性,为疫情防控提供经验。
本研究从各官方网站提取 COVID-19 官方数据,总结美国和印度的政策措施,并评估其政策的有效性。
美国采取了一系列缓解策略来控制两次疫情浪潮,包括加强病毒检测、呼吁民众戴口罩等。截至 2021 年 5 月 30 日,尽管每日新增病例有所下降,但效果并不理想。美国的每日新增病例数排名第四,累计确诊病例数排名世界第一。印度在疫情爆发初期采取了遏制策略,使疫情相对稳定。后期,印度转而采取缓解策略。此外,医疗资源缺乏和过早放宽措施等诸多因素导致疫情迅速恶化。截至 2021 年 5 月 30 日,尽管印度的每日新增病例呈下降趋势,但仍居世界首位,累计确诊病例数排名第二。
美国和印度采取的疫情防控策略存在差异,特别是印度的遏制策略帮助其在早期更好地控制了疫情。然而,两国的疫情仍很严重。随着病毒突变体的出现和免疫屏障的缺失,两国继续采取非药物治疗干预措施并加快疫苗接种,根据具体国情在必要时采取能够更快控制疫情的遏制策略,并注意因过早放宽防疫政策而导致疫情反弹的风险,具有重要意义。